Literature DB >> 23325686

Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Christelle Brégnard1, Alessia Zamborlini, Marjorie Leduc, Philippe Chafey, Luc Camoin, Ali Saïb, Serge Benichou, Olivier Danos, Stéphane Basmaciogullari.   

Abstract

Nef is a human immunodeficiency virus type 1 (HIV-1) auxiliary protein that plays an important role in virus replication and the onset of acquired immunodeficiency. Although known functions of Nef might explain its contribution to HIV-1-associated pathogenesis, how Nef increases virus infectivity is still an open question. In vitro, Nef-deleted viruses have a defect that prevents efficient completion of early steps of replication. We have previously shown that this restriction is not due to the absence of Nef in viral particles. Rather, a loss of function in virus-producing cells accounts for the lower infectivity of nef-deleted viruses compared to wild-type (WT) viruses. Here we used DiGE and iTRAQ to identify differences between the proteomes of WT and nef-deleted viruses. We observe that glucosidase II is enriched in WT virions, whereas Ezrin, ALG-2, CD81, and EHD4 are enriched in nef-deleted virions. Functional analysis shows that glucosidase II, ALG-2, and CD81 have no or only Nef-independent effect on infectivity. In contrast, Ezrin and EHD4 are involved in the ability of Nef to increase virus infectivity (referred to thereafter as Nef potency). Indeed, simultaneous Ezrin and EHD4 depletion in SupT1 and 293T virus-producing cells result in an ∼30 and ∼70% decrease of Nef potency, respectively. Finally, while Ezrin behaves as an inhibitory factor counteracted by Nef, EHD4 should be considered as a cofactors required by Nef to increase virus infectivity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23325686      PMCID: PMC3624205          DOI: 10.1128/JVI.02477-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  87 in total

1.  Nef enhances HIV-1 infectivity via association with the virus assembly complex.

Authors:  Mingli Qi; Christopher Aiken
Journal:  Virology       Date:  2008-01-14       Impact factor: 3.616

2.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

3.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

4.  The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability.

Authors:  Jonas M la Cour; Berit R Høj; Jens Mollerup; Ronald Simon; Guido Sauter; Martin W Berchtold
Journal:  Mol Oncol       Date:  2007-08-19       Impact factor: 6.603

5.  A role for EHD4 in the regulation of early endosomal transport.

Authors:  Mahak Sharma; Naava Naslavsky; Steve Caplan
Journal:  Traffic       Date:  2008-03-06       Impact factor: 6.215

6.  The Ezrin-radixin-moesin family member ezrin regulates stable microtubule formation and retroviral infection.

Authors:  Juliane Haedicke; Kenia de Los Santos; Stephen P Goff; Mojgan H Naghavi
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

7.  Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

Authors:  Massimo Pizzato; Elena Popova; Heinrich G Göttlinger
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

8.  Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes.

Authors:  Marta Barrero-Villar; José Román Cabrero; Mónica Gordón-Alonso; Jonathan Barroso-González; Susana Alvarez-Losada; M Angeles Muñoz-Fernández; Francisco Sánchez-Madrid; Agustín Valenzuela-Fernández
Journal:  J Cell Sci       Date:  2008-12-09       Impact factor: 5.285

9.  A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line.

Authors:  Boyan Grigorov; Valérie Attuil-Audenis; Fabien Perugi; Martine Nedelec; Sarah Watson; Claudine Pique; Jean-Luc Darlix; Hélène Conjeaud; Delphine Muriaux
Journal:  Retrovirology       Date:  2009-03-11       Impact factor: 4.602

10.  VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability.

Authors:  Sonia Brun; Maxime Solignat; Bernard Gay; Eric Bernard; Laurent Chaloin; David Fenard; Christian Devaux; Nathalie Chazal; Laurence Briant
Journal:  Retrovirology       Date:  2008-07-07       Impact factor: 4.602

View more
  22 in total

1.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Ezrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion.

Authors:  Nathan H Roy; Marie Lambelé; Jany Chan; Menelaos Symeonides; Markus Thali
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Authors:  Yoshiko Usami; Sergei Popov; Heinrich G Göttlinger
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

4.  Structural and Functional Study of Apoptosis-linked Gene-2·Heme-binding Protein 2 Interactions in HIV-1 Production.

Authors:  Jing Ma; Xianfeng Zhang; Yanbin Feng; Hui Zhang; Xiaojun Wang; Yonghui Zheng; Wentao Qiao; Xinqi Liu
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

5.  Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.

Authors:  Marie Lambelé; Herwig Koppensteiner; Menelaos Symeonides; Nathan H Roy; Jany Chan; Michael Schindler; Markus Thali
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

6.  Tight-Binding Hydroxypyrazole HIV-1 Nef Inhibitors Suppress Viral Replication in Donor Mononuclear Cells and Reverse Nef-Mediated MHC-I Downregulation.

Authors:  Haibin Shi; Colin M Tice; Lori Emert-Sedlak; Li Chen; Wing Fai Li; Marianne Carlsen; Jay E Wrobel; Allen B Reitz; Thomas E Smithgall
Journal:  ACS Infect Dis       Date:  2019-12-16       Impact factor: 5.084

7.  Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry.

Authors:  Jason DeBoer; Melinda S Wojtkiewicz; Nicole Haverland; Yan Li; Emma Harwood; Emily Leshen; Joseph W George; Pawel Ciborowski; Michael Belshan
Journal:  Virology       Date:  2018-03       Impact factor: 3.616

Review 8.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

Review 9.  Inside job: how the ESCRTs release HIV-1 from infected cells.

Authors:  James H Hurley; A King Cada
Journal:  Biochem Soc Trans       Date:  2018-08-28       Impact factor: 5.407

Review 10.  Proteomics in the investigation of HIV-1 interactions with host proteins.

Authors:  Ming Li
Journal:  Proteomics Clin Appl       Date:  2015-01-19       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.